Clinical trial
A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
NCT00115973 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00115973 |
|---|---|
| Title | A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump |
| Official title | An Open-Label, Stepwise Basal Insulin Dose Titration Study Using Continuous Subcutaneous Insulin Infusion (CSII) in Oral Antidiabetic Drug-Treated Type 2 Diabetes Mellitus Subjects Followed by a 10-Week Out-Patient Maintenance Phase |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2, Delivery Systems |
| Intervention type | Device, Drug |
| Interventions | pump, insulin aspart |
| Enrollment | 71 |
| Start date | Jun 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Jun 27, 2005 |
| Last update posted | Oct 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: